Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation

Neoplasia

Volumn 9, Issue 12, 2007, Pages 1111-1121

  Campos, Ana C E ^a   Molognoni, Fernanda ^a   Melo, Fabiana H M ^a   Galdieri, Luciano C ^a   Carneiro, Célia R W ^a   D'Almeida, Vânia ^a   Correa, Mariangela ^a   Jasiulionis, Miriam G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anoikis; Carcinogenesis; DNA methylation; Epigenetics; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; GLUTATHIONE; HOMOCYSTEINE; MELAN A; METHIONINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL ANCHORAGE; CONTROLLED STUDY; DNA METHYLATION; MALIGNANT TRANSFORMATION; MELANOCYTE; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 37149010874     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07712     Document Type: Article

References (75)

1. Frisch SM and Screaton RA (2001). Anoikis mechanisms. Curr Opin Cell Biol 13, 555-562.
2. Grossmann J (2002). Molecular mechanisms of "detachment-induced apoptosis - anoikis". Apoptosis 7, 247-260.
3. Cheng TL, Symons M, and Jou TS (2004). Regulation of anoikis by Cdc42 and Rac1. Exp Cell Res 295, 497-511.
4. Kawanishi S, Hiraku Y, and Oikawa S (2001). Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 488, 65-76.
5. Eu JP, Liu L, Zeng M, and Stamler JS (2000). An apoptotic model for nitrosative stress. Biochemistry 39, 1040-1047.
6. Cavelier G (2000). Theory of malignant cell transformation by superoxide fate coupled with cytoskeletal electron-transport and electron-transfer. Med Hypotheses 54, 95-98.
7. 1/S cell cycle transition by regulating intracellular ROS. Blood 102, 3179-3185.
8. Zimmerman R and Cerutti P (1984). Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts. Proc Natl Acad Sci USA 81, 2085-2087.
9. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and GoldschmidtClermont PJ (1997). Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 275, 1649-1652.
10. Behrend L, Henderson G, and Zwacka RM (2003). Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31, 1441-1444.
11. Brune B, von Knethen A, and Sandau KB (1999). Nitric oxide (NO): an effector of apoptosis. Cell Death Differ 6, 969-975.
12. Ischiropoulos H and Beckman JS (2003). Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111, 163-169.
13. Creppy EE, Traore A, Baudrimont I, Cascante M, and Carratu MR (2002). Recent advances in the study of epigenetic effects induced by the phycotoxin okadaic acid. Toxicology 181-182, 433-439.
14. Marnett LJ, Riggins JN, and West JD (2003). Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest 111, 583-593.
15. Valinluck V, Tsai H, Rogstad DK, Burdzy A, Bird A, and Sowers LC (2004). Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32, 4100-4108.
16. Gowher H, Liebert K, Hermann A, Xu G, and Jeltsch A (2005). Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5) - methyltransferases by Dnmt3L. J Biol Chem 280, 13341-13348.
17. Suetake I, Shinozaki F, Miyagawa J, Takeshima H, and Tajima S (2004). DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. J Biol Chem 279, 27816-27823.
18. Jones PA and Baylin SB (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428.
19. Feinberg AP, Ohlsson R, and Henikoff S (2006). The epigenetic progenitor origin of human cancer. Nat Rev Genet 7, 21-33.
20. Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, Adamson E, Mercola D, and McClelland M (2005). Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7, 748-760.
21. Correa M, Machado J Jr, Carneiro CR, Pesquero JB, Bader M, Travassos LR, Chammas R, and Jasiulionis MG (2005). Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer 114, 356-363.
22. Oba-Shinjo SM, Correa M, Ricca TI, Molognoni F, Pinhal MA, Neves IA, Marie SK, Sampaio LO, Nader HB, Chammas R, et al. (2006). Melanocyte transformation associated with substrate adhesion impediment. Neoplasia 8, 231-241.
23. Bennett DC, Cooper PJ, and Hart IR (1987). A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 39, 414-418.
24. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar B, and Kalyanaraman B (2003). Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34, 1359-1368.
25. Tietze F (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27, 502-522.
26. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
27. Kojima H, Nakatsubo N, Kikuchi K, Urano Y, Higuchi T, Tanaka J, Kudo Y, and Nagano T (1998). Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator: DAF-2 DA. Neuroreport 9, 3345-3348.
28. Hampl V, Waters CL, and Archer SL (1996). Determination of nitric oxide by the chemiluminescence reaction with ozone. In Feelisch, M, Stamler, JS (Eds.), Methods in Nitric Oxide Research, pp. 309-318 John Wiley & Sons, Chichester.
29. Ohkawa H, Ohishi N, and Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
30. Pfeiffer CM, Huff DL, and Gunter EW (1999). Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45, 290-292.
31. Milutinovic S, Zhuang Q, Niveleau A, and Szyf M (2003). Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra - S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 278, 14985-14995.
32. Meyskens FL Jr, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, and Gonzalez RI (2001). Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radic Biol Med 31, 799-808.
33. Tchantchou F, Graves M, Ashline D, Morin A, Pimenta A, Ortiz D, Rogers E, and Shea TB (2004). Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E, and apolipoprotein E. J Neurosci Res 75, 508-515.
34. Zorov DB, Bannikova SY, Belousov VV, Vyssokikh MY, Zorova LD, Isaev NK, Krasnikov BF, and Plotnikov EY (2005). Reactive oxygen and nitrogen species: friends or foes? Biochemistry (Mosc) 70, 215-221.
35. Warner DS, Sheng H, and Batinic-Haberle I (2004). Oxidants, antioxidants and the ischemic brain. J Exp Biol 207, 3221-3231.
36. Mosharov E, Cranford MR, and Banerjee R (2000). The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 39, 13005-13011.
37. Dimitrova KR, DeGroot K, Myers AK, and Kim YD (2002). Estrogen and homocysteine. Cardiovasc Res 53, 577-588.
38. Caudill MA, Wang JC, Melnyk S, Pogribny IP, Jernigan S, Collins MD, Santos-Guzman J, Swendseid ME, Cogger EA, and James SJ (2001). Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine β-synthase heterozygous mice. J Nutr 131, 2811-2818.
39. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and GoldschmidtClermont PJ (1997). Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science 275, 1649-1652.
40. Salvucci O, Carsana M, Bersani H, Tragni G, and Anichini A (2001). Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 61, 318-326.
41. Moroz LL, Norby SW, Cruz L, Sweedler JV, Gillete R, and Clarkson RB (1998). Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors. Biochem Biophys Res Commun 253, 571-576.
42. Kincannon J and Boutzale C (1999). The physiology of pigmented nevi. Pediatrics 104, 1042-1045.
43. Postovit LM, Seftor EA, Seftor RE, and Hendrix MJ (2006). Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Res 66, 7833-7836.
44. Li N, Oberley TD, Oberley LW, and Zhong W (1998). Inhibition of cell growth in NIH/3T3 fibroblasts by overexpression of manganese superoxide dismutase: mechanistic studies. J Cell Physiol 175, 359-369.
45. Laguinge LM, Lin S, Samara RN, Salesiotis AN, and Jessup JM (2004). Nitrosative stress in rotated three-dimensional colorectal carcinoma cell cultures induces microtubule depolymerization and apoptosis. Cancer Res 64, 2643-2648.
46. Pervaiz S, Cao J, Chao OS, Chin YY, and Clement MV (2001). Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene 20, 6263-6268.
47. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, et al. (2005). Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 65, 948-956.
48. Nair VD, Yuen T, Olanow CW, and Sealfon SC (2004). Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem 279, 27494-27501.
49. Haddad JJ (2004). Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno - pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol 4, 475-493.
50. Ulrey CL, Liu L, Andrews LG, and Tollefsbol TO (2005). The impact of metabolism on DNA methylation. Hum Mol Genet 14 Spec No 1, R139-R147.
51. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, and James SJ (2000). Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275, 29318-29323.
52. Weitzman SA, Turk PW, Milkowski DH, and Kozlowski K (1994). Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA 91, 1261-1264.
53. Cerda S and Weitzman SA (1997). Influence of oxygen radical injury on DNA methylation. Mutat Res 386, 141-152.
54. Hmadcha A, Bedoya FJ, Sobrino F, and Pintado E (1999). Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production. J Exp Med 190, 1595-1604.
55. Nagata K, Iwasaki Y, Yamada T, Yuba T, Kono K, Hosogi S, Ohsugi S, Kuwahara H, and Marunaka Y (2007). Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med 101, 800-807.
56. Xia Z, Guo Z, Nagareddy PR, Yuen V, Yeung E, and McNeill JH (2006). Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol 544, 125.
57. Rabelink TJ and Luscher TF (2006). Endothelial nitric oxide synthase. Host defense enzyme of the endothelium? Arterioscler Thromb Vasc Biol 26, 267-271.
58. Cardounel AJ, Xia Y, and Zweier JL (2005). Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase. J Biol Chem 280, 7540-7549.
59. Pou S, Keaton L, Surichamorn W, and Rosen GM (1999). Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem 274, 9573-9580.
60. Meininger CJ, Cai S, Parker JL, Channon KM, Kelly KA, Becker EJ, Wood MK, Wade LA, and Wu G (2004). GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats. FASEB J 18, 1900-1902.
61. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher TF, and Rabelink TJ (1997). Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99, 41-46.
62. Zou MH, Shi C, and Cohen RA (2002). Oxidation of the zinc - thiolate complex and uncoupling of endothelial nitric synthase by peroxynitrite. J Clin Invest 109, 817-826.
63. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, and Cooke JP (2001). Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104, 2569-2575.
64. Barbacid M (1987). Ras genes. Annu Rev Biochem 56, 779-827.
65. Derouet M, Xou X, May L, Hoon Yoo B, Sasazuki T, Shirasawa S, Rak J, and Rosen KV (2007). Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo. Neoplasia 9, 536-545.
66. MacLeod R, Rouleau J, and Szyf M (1995). Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem 270, 11327-11337.
67. Chang H, Cho C, and Hung W (2006). Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res 66, 8413-8420.
68. Soejima K, Fang W, and Rollins BJ (2003). DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene 22, 4723-4733.
69. Pruitt K, Ulku AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, and Shields JM (2005). Ras-mediated loss of the proapoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 280, 23363-23370.
70. Sephashvili M, Zhuravliova E, Barbakadze T, Khundadze M, Narmania N, and Mikeladze DG (2006). L-NAME has opposite effects on the productions of S-adenosylhomocysteine and S-adenosylmethionine in V12-H-Ras and M-CR3B-Ras pheochromocytoma cells. Neurochem Res 31, 1205-1210.
71. Baserga R (1997). The price of independence. Exp Cell Res 236, 1-3.
72. Song J, Xie H, Lian J, Yang G, Du R, Du Y, Zou X, Jin H, Gao J, Liu J, et al. (2006). Enhanced cell survival of gastric cancer cells by a novel gene URG4. Neoplasia 8, 995-1002.
73. Rak J, Mitsuhashi Y, Sheehan C, Krestow J, Florenes V, Filmus J, and Kerbel R (1999). Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis. Neoplasia 1, 23-30.
74. Zhu Z, Sanchez-Sweatman O, Huang X, Wiltrout R, Khokha R, Zhao Q, and Gorelik E (2001). Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 61, 1707-1716.
75. Seftor EA, Brown KM, Chin L, Kirschmann DA, Wheaton WW, Protopopov A, Feng B, Balagurunathan Y, Trent JM, Nickoloff BJ, et al. (2005). Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. Cancer Res 65, 10164-10169.